Of the hundreds of ongoing drug shortages in the U.S., some are lifesaving cancer medications and 14 are among the 20 most commonly prescribed. 

Pfizer discontinued its research into the obesity drug candidate lotiglipron after phase 1 and 2 studies found elevated transaminases, or liver enzymes, in participants, the drugmaker said June 26. 

The FDA has given a fast-track designation to a drug designed to prevent infection from both influenza A and B strains created by San Diego-based Cidara Therapeutics, according to a June 22 news release.

The FDA approved the first gene therapy for some pediatric patients with Duchenne muscular dystrophy, a rare genetic condition that weakens the body's muscles, on June 22. 

People 60 and older "may" get a respiratory syncytial virus vaccine — that is what a CDC advisory panel voted June 21, stopping short of what was anticipated to be a stronger recommendation that older adults "should" get the shots. 

Keene, N.H.-based Cheshire Medical Center will pay $2 million in connection with an incident in which gallons of fentanyl solution were lost or unaccounted for in a four-month period.

Fifty-two percent of active pharmaceutical ingredients used in U.S. medications are made outside the country, according to an annual report from the FDA. 

The FDA granted full approval to two drugs June 20 — Jardiance and Synjardy, both manufactured by Boehringer Ingelheim —  for the treatment of pediatric Type 2 diabetes. Now, children with the condition will have three options for approved therapies.

UPMC is teaming up with PharmaLogic Holdings to construct one of the largest U.S.-based facilities for radiopharmaceutical research, production and distribution in Pittsburgh, the two organizations said June 21. 

Cone Health tapped Andre Harvin, PharmD, as its new chief pharmacy officer June 21.